[ad_1]
The FDA declared Tuesday that all vaccine manufacturers must provide the authority with two-month data from a full trial of the vaccine they are working on. This is to ensure that subjects do not suffer from serious side effects.
Only then comes FDA to decide whether an experimental vaccine can be used as the so-called emergency vaccine. This is stated by the Reuters news agency, which has read the documents of the case.
The information comes from documents sent by the FDA to vaccine manufacturers.
The White House still has a chance to bypass the FDA’s recommendations, but if the agency is allowed to follow its own recommendations, it is unlikely that there will be a vaccine approved until late November.
The United States Presidential Elections takes place on November 3 and President Donald Trump has said on several occasions that he thinks there should be a vaccine before then.
The government vaccine project Operation warp speed declared on Tuesday that data on the effectiveness of one or two candidate vaccines will be available in a couple of months and that there will be enough doses to vaccinate 30 million Americans in November and December, writes Reuters .
On Tuesday, the director general of the World Health Organization, WHO, Tedros Adhanom Ghebreyesus, also said he believes a vaccine could be ready before the end of the year.
